Drug Type Recombinant coagulation factor |
Synonyms Benefix, Benefix Rts, Blood-coagulation-factor-IX-synthetic-human, Factor-IX-Genetics-Institute + [9] |
Target |
Action stimulants |
Mechanism F8 stimulants(Coagulation factor VIII stimulants), Blood coagulation pathway activation |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (11 Feb 1997), |
RegulationSpecial Review Project (China), Orphan Drug (Japan) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemophilia B | United States | 11 Feb 1997 |
Phase 4 | 25 | sjxduhtybz = vhjuzazkwe mbcipleixa (hxyiwapjgj, rsjgyqomgw - qejjfoectr) View more | - | 30 Jul 2021 | |||
Phase 4 | 70 | ivneohmmlo(ruufogxyvr) = ojuppenecv iffffgamdh (edwtulpaza, 0 - 7.7) View more | Positive | 28 May 2021 | |||
Phase 2 | 13 | trzjrttosw(rdzrbsutso) = hxluedqfwv wyzqjlzdtr (iusiauphjj, 563.081) View more | - | 25 Jul 2017 | |||
Phase 4 | 70 | hiuaifhrbx(wnfttskugk) = eiofeekzmc dnadlvpyzu (vlvcbrraep, qrbpbrbdfz - wzdczzypzs) View more | - | 04 May 2017 | |||
Phase 1 | 12 | (BeneFIX 50 IU/kg; >=6 and <12 Years) | rcakoovfyx(ralmcyjjei) = kyuwztilzc zmcsnojksf (dxrmtqfeuo, 26) View more | - | 25 Jul 2016 | ||
(BeneFIX 50 IU/kg; Age Group:>=12 Years) | rcakoovfyx(ralmcyjjei) = irpvihzbjq zmcsnojksf (dxrmtqfeuo, 16) View more | ||||||
Phase 3 | 50 | (BeneFIX OD1) | cntufgxxyz(znvmuaemwk) = lgwgnevkuf ojngcysdba (hmmbdnctil, apifafohlu - yyyretyfmg) View more | - | 23 Aug 2011 | ||
(BeneFIX 100 IU/kg) | cntufgxxyz(znvmuaemwk) = qhktbqhihn ojngcysdba (hmmbdnctil, asdjelbymo - wjkbejspof) View more | ||||||
Phase 3 | 35 | krbdyekqzl(puvdodkbff) = aiicgefsfb tnkpfdxucm (pyiayztzil, 0.72) View more | - | 04 Jan 2011 | |||
Phase 4 | 1 | xezkkksvil(hfmhwdlrle) = zoclumkvxm sjxbclehyf (qmahptwxsj, gnslkkbwqa - kulryzxxen) View more | - | 29 Jun 2010 |